The purpose of this bill is to increase patients’ access to medicines by reducing some of the barriers to access currently in the Medicines Act 1981.
Medicines industry ‘dodges a bullet’ with tariff exemption – for now
Medicines industry ‘dodges a bullet’ with tariff exemption – for now
New Zealand’s pharmaceutical sector is cautiously optimistic over the industry being granted an exemption from US President Donald Trump’s tariffs.